SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-016000
Filing Date
2017-08-07
Accepted
2017-08-07 16:19:16
Documents
58
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q dvax-10q_20170630.htm 10-Q 1733448
2 EX-10.2 dvax-ex102_42.htm EX-10.2 109515
3 EX-31.1 dvax-ex311_14.htm EX-31.1 17959
4 EX-31.2 dvax-ex312_15.htm EX-31.2 17873
5 EX-32.1 dvax-ex321_13.htm EX-32.1 6080
6 EX-32.2 dvax-ex322_12.htm EX-32.2 6332
  Complete submission text file 0001564590-17-016000.txt   6155607

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT dvax-20170630.xml EX-101.INS 1352060
8 XBRL TAXONOMY EXTENSION SCHEMA dvax-20170630.xsd EX-101.SCH 36179
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dvax-20170630_cal.xml EX-101.CAL 43604
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dvax-20170630_def.xml EX-101.DEF 135909
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE dvax-20170630_lab.xml EX-101.LAB 327812
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dvax-20170630_pre.xml EX-101.PRE 249119
Mailing Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710
Business Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

IRS No.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34207 | Film No.: 171011729
SIC: 2834 Pharmaceutical Preparations